Would you consider local therapy (e.g. XRT) in patients with mRCC with oligometastatic disease progression?

If current systemic treatment is otherwise controlling the disease and is well-tolerated, is there value to locally aggressive therapy in an attempt to preserve future treatment options?

Answer from: Medical Oncologist at Academic Institution

This is a good question. The role of local therapy in mRCC should (in my opinion) be limited to 2 settings. a) A patient with mRCC who is experiencing pain from a metastatic site. b) A patient with an indolent disease course and overall low volume of metastatic disease in whom local therapy ...

Comments

Medical Oncologist at University of Washington School of Medicine
Agree. May add that in some cases, SBRT to a singl...

Please select the option that best describes you:

Would you consider local therapy (e.g. XRT) in patients with mRCC with oligometastatic disease progression?

Related Questions